Monday, February 23, 2026 | 06:22 PM ISTहिंदी में पढें
Morepen Laboratories Ltd News
Morepen Labs wins ₹825 crore long-term CDMO deal with global drugmaker
Morepen Labs has secured a ₹825 crore multi-year CDMO mandate from a global pharma major, with supplies set to begin in 4-5 months and execution running through Q1 FY27
 "Morepen Labs wins ₹825 crore long-term CDMO deal with global drugmaker")
Updated On : 23 Feb 2026 | 3:33 PM IST
Morepen Labs share price zooms 16% on winning ₹825 crore global order
Morepen Laboratories share price jumped 15.7 per cent to the day's high of ₹45.40 per share on the National Stock Exchange (NSE)
 "Morepen Labs share price zooms 16% on winning ₹825 crore global order")
Updated On : 23 Feb 2026 | 11:49 AM IST
Morepen Labs wins ₹825 crore manufacturing contract from global drugmaker
Morepen Laboratories said supplies under the contract are expected to begin within the next four to five months, while execution is scheduled through the first quarter of the financial year 2026-27
Updated On : 23 Feb 2026 | 10:40 AM IST
Morepen Laboratories shares jump 6%; what's driving buying interest?
Morepen Laboratories shares jumped 5.7 per cent, after the company arm Morepen Medipath executed a joint venture (JV) agreement with Bimedical FZE, a UAE based entity
 "Morepen Laboratories shares jump 6%; what's driving buying interest?")
Updated On : 09 Sep 2025 | 10:28 AM IST